KEGG   DISEASE: 黄斑浮腫
エントリ  
H01651                                                             
名称    
黄斑浮腫
概要    
Macular edema is a common feature of many diseases of the retina, such as intraocular inflammation (uveitis), central or branch retinal vein occlusion, diabetic retinopathy and following cataract extraction. It is characterized by a retinal thickening in the macular area due to the breakdown of the blood-retinal barrier. Extracellular fluid accumulates in the intraretinal area or collects in the subretinal space. In more severe cases, it occurs as cystoid edema with the typical petaloid appearance, and is the leading cause of visual loss. New treatments for macular edema have emerged over the past decade, the most recent and efficacious of which have involved blockage of vascular endothelial growth factor (VEGF) by frequent intravitreal injection of pharmacologic agents.
カテゴリ  
神経系疾患
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 09 視覚系の疾患
  眼球後極部の疾患
   網膜の疾患
    9B75  黄斑疾患
     H01651  黄斑浮腫
治療薬   
トリアムシノロンアセトニド [DR:D00983]
アフリベルセプト [DR:D09574]
ラニビズマブ [DR:D05697]
ブロルシズマブ [DR:D11083]
ファリシマブ [DR:D11516]
リンク   
ICD-11: 9B75.Y
MeSH: D008269
OMIM: 153880
文献    
  著者
Rotsos TG, Moschos MM
  タイトル
Cystoid macular edema.
  雑誌
Clin Ophthalmol 2:919-30 (2008)
DOI:10.2147/opth.s4033
文献    
  著者
Romero-Aroca P
  タイトル
Managing diabetic macular edema: The leading cause of diabetes blindness.
  雑誌
World J Diabetes 2:98-104 (2011)
DOI:10.4239/wjd.v2.i6.98
文献    
  著者
Fardeau C, Champion E, Massamba N, LeHoang P
  タイトル
Uveitic macular edema.
  雑誌
Eye (Lond) 30:1277-1292 (2016)
DOI:10.1038/eye.2016.115
文献    
  著者
Andreoli MT, Pinnolis M, Kieser T, Sun J, Andreoli CM
  タイトル
Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration.
  雑誌
Digit J Ophthalmol 21:1-17 (2015)
DOI:10.5693/djo.01.2015.04.002
LinkDB    

» English version

DBGET integrated database retrieval system